Roquefort Therapeutics (ROQ) Insider Trading & Ownership GBX 5.13 -0.47 (-8.43%) (As of 11/1/2024 12:39 PM ET) Add Compare Share Share Insider Trades Stock AnalysisChartCompetitorsInsider Trades Roquefort Therapeutics (LON:ROQ) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage60.40%Number OfInsiders Buying(Last 3 Years)3Amount OfInsider Buying(Last 3 Years)£102,532.26Number OfInsiders Selling(Last 3 Years)0 Get ROQ Insider Trade Alerts Want to know when executives and insiders are buying or selling Roquefort Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address ROQ Insider Buying and Selling by Quarter Ad The Freeport SocietyMusk warns humanity: “Obsolete”The 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern border is a travesty, but the 'invasion' I've found will have 10 times greater effects on our economy, and ultimately our way of life.Go here to see why. Roquefort Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails8/1/2023Dr Darrin DisleyInsiderBuy269,935GBX 7£18,895.457/12/2023Stephen Paul WestInsiderBuy15,730GBX 6£943.806/26/2023Stephen Paul WestInsiderBuy144,117GBX 7£10,088.196/23/2023Trevor Ajanthan (Ajan) ReginaldInsiderBuy35,265GBX 7£2,468.559/26/2022Dr Darrin DisleyInsiderBuy515,913GBX 8£41,273.047/4/2022Stephen Paul WestInsiderBuy210,000GBX 9£18,9006/30/2022Stephen Paul WestInsiderBuy55,147GBX 9£4,963.231/19/2022Stephen Paul WestInsiderBuy50,000GBX 10£5,000 (Data available from 1/1/2013 forward) ROQ Insider Trading Activity - Frequently Asked Questions Who is on Roquefort Therapeutics's Insider Roster? The list of insiders at Roquefort Therapeutics includes Dr Darrin Disley, Stephen Paul West, and Trevor Ajanthan (Ajan) Reginald. Learn more on insiders at ROQ. What percentage of Roquefort Therapeutics stock is owned by insiders? 60.40% of Roquefort Therapeutics stock is owned by insiders. Learn more on ROQ's insider holdings. Which Roquefort Therapeutics insiders have been buying company stock? The following insiders have purchased ROQ shares in the last 24 months: Dr Darrin Disley (£18,895.45), Stephen Paul West (£11,031.99), and Trevor Ajanthan (Ajan) Reginald (£2,468.55). How much insider buying is happening at Roquefort Therapeutics? Insiders have purchased a total of 465,047 ROQ shares in the last 24 months for a total of £32,395.99 bought. Roquefort Therapeutics Key ExecutivesMr. Stephen Paul West B.Com (Age 52)CA, Executive Chairman Compensation: $152.9kMr. Trevor Ajanthan Reginald (Age 52)CEO & Executive Director Compensation: $305.8kProf. Martin J. Evans FRS (Age 83)Group Chief Scientific Officer & Executive Director Compensation: $100kDr. Emma MorrisHead of Pre-Clinical Research More Insider Trading Tools from MarketBeat Related Companies ONC Insider Trades BVX Insider Trades FAB Insider Trades OBD Insider Trades DEST Insider Trades RENE Insider Trades OCTP Insider Trades GNS Insider Trades ONT Insider Trades OXB Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Big Buybacks Announced: 3 Stocks Insiders Are Banking OnInsiders Are Buying High-Yielding Delek Logistics PartnersInsider Selling is not a Signal to Start Selling Gartner Stock2 Stocks to Buy and 1 to Sell - Smart Moves for Investors3 Mid-Cap Stocks Under $20 With Insider Buying and Major Upside This page (LON:ROQ) was last updated on 11/2/2024 by MarketBeat.com Staff From Our PartnersMusk warns humanity: “Obsolete”The 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin...Weiss Ratings | SponsoredHow Will You Survive A Post Election Retirement Heist?The clock is ticking, and your life savings are in an extremely vulnerable position. We are a few days away...American Hartford Gold Group | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Roquefort Therapeutics plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Roquefort Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
